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SUMMARY
Malaria in Brazil is endemic in the Amazon region, but autochthonous cases with low parasitaemia occur in the Atlantic Forest 
area of the country. According to Brazilian legislation no test is mandatory for blood donors from non-endemic areas. However if 
they have traveled to malaria transmission regions they are deferred for six months before they can donate. This report describes a 
transfusion-transmitted malaria case in Sao Paulo, Brazil, where one recipient received infected blood and developed the disease. 
He lived in Sao Paulo and had no previous transfusion or trips to endemic areas, including those of low endemicity, such as Atlantic 
Forest. Thick blood smears confirmed Plasmodium malariae. All donors lived in Sao Paulo and one of them (Donor 045-0) showed 
positive hemoscopy and PCR. This asymptomatic donor had traveled to Juquia, in the Atlantic Forest area of Sao Paulo State, where 
sporadic cases of autochthonous malaria are described. DNA assay revealed P. malariae in the donor’s (Donor 045-0) blood. Serum 
archives of the recipient and of all blood donors were analyzed by ELISA using both P. vivax and P. falciparum antigens, and IFAT 
with P. malariae. Donor 045-0’s serum was P. malariae IFAT positive and the P. vivax ELISA was reactive. In addition, two out of 44 
donors’ archive sera were also P. vivax ELISA reactive. All sera were P. falciparum ELISA negative. This case suggests the need of 
reviewing donor selection criteria and deferral strategies to prevent possible cases of transfusion-transmitted malaria.
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INTRODUCTION
Malaria occurs in more than 100 countries in the tropical and 
subtropical regions including parts of Asia, Africa, Oceania, Central and 
South America. Half of the world’s population is at risk of malaria and an 
estimated 243 million cases led to nearly 863,000 deaths in 2008, mostly 
in children living in sub-Saharan Africa34. In Brazil, 306,908 cases were 
notified in 2009, being 306,342 in the Amazon region, where malaria is 
endemic5. P. vivax is the most common species (84.4%), followed by P. 
falciparum (14.6%), mixed infections (0.9%) and P. malariae (0.02%)3, 
however it is important to note that P. malariae may be misdiagnosed 
due to the difficulty of differentiating it from P. vivax. Outside of the 
Amazon region the National Malaria Control Program notified 154 
autochthonous cases in 20084.
Data about the frequency of transfusion transmitted malaria show 
values that vary from less than 0.2 in non-endemic countries to 50 or 
more cases per million in endemic countries6 and the species most 
frequently associated with transfusional cases are P. falciparum, P. 
malariae and P. vivax. The donors implicated in this kind of transmission 
are invariably semi-immune, with parasite levels below the detection 
threshold of currently available assays. As the result of the asymptomatic 
persistence of parasites, transmission has been documented after the 
last exposure as long as 44 years for P. malariae, five years for P. vivax 
and eight years for P. falciparum23,27. Besides that, parasites can survive 
in blood at temperatures between 2 ºC and 6 ºC for until three weeks, 
with the estimated inoculum in transfusions from one to 10 parasites 
per donation7,20,31. Whole blood and red blood cell units are the primary 
carriers of malaria transmitted by transfusion, although platelets and 
leukocytes may contain variable numbers of red cells and have, rarely, 
transmitted malaria12,18,35. 
In endemic regions transfusion transmitted malaria has frequently 
been described. In a recent prospective study in Pakistan, healthy 
volunteer blood donors were screened by thick blood smear and showed 
0.57% positivity, with one case of P. falciparum and eight due to P. 
vivax1. In a study conducted in India 11,736 units of blood were screened 
from 2008 to 2009, with 0.03% positivity using rapid diagnostic tests 
that was confirmed by microscopy2. In Nigeria, where blood donors are 
not routinely tested for malarial infection, potential blood donors were 
screened, resulting in a positivity of 20.2% by microscopy, 3.8% by 
OptiMAL and 57.8% by Clinotech16. 
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The risk of transfusion-transmitted malaria differs widely among low 
endemic countries, where the imported infection occurs in individuals 
that have traveled to or migrated from endemic regions24. In a survey 
conducted in 14 national transfusion services centers in different 
countries, the use of serological tests for malaria in donor screening was 
reported as a routine only in four countries (United Kingdom, Denmark, 
Finland and New Zealand). Those with positive serology are confirmed 
by rapid tests for detection of antigens in New Zealand and nucleic acid 
testing (NAT) in the United Kingdom where no case of transfusion-
transmitted malaria was diagnosed during the last 5 years28.
According to Brazilian guidelines there are different recommendations 
for endemic and non-endemic regions. The endemic area is classified 
into low, medium or high risk, based on the Annual Parasite Index. In 
endemic areas those donors who have had malaria in the 12 months 
preceding the donation and those coming from areas of high malaria risk 
are rejected, as well as those donors that presented fever or are suspected 
of having malaria in the last 30 days. Donors from areas of medium and 
low risk can be accepted after a negative thick film or rapid malaria test. 
In non-endemic areas testing is not required nor performed, but donors 
who were in an endemic area with active transmission in the last six 
months and those that have had malaria or resided in endemic areas in 
the last three years are excluded. In both endemic and non-endemic areas 
donors who have had infection with P. malariae are excluded29. Some 
transfusion services use antibody assays such as Indirect Fluorescent 
Antibody Test (IFAT) and enzyme-linked immunosorbent assay (ELISA) 
in addition to antigenic tests. Molecular tests are used only for diagnosis 
or research in reference centers. Even in non-endemic areas and with all 
the precautionary measures being taken, exclusion of all ‘malaria risk’ 
individuals is not possible. 
A further limitation to travel-based restrictions is that the long periods 
of asymptomatic carriage, particularly associated with P. malariae, also 
mean that donors can harbor parasites even after their exclusion period. 
Besides that, current strategies to reduce the likelihood of transfusion 
transmitted infections in non-endemic countries invariably involve 
discarding blood from potentially exposed donors, possibly leading to 
wastage of donations. 
In the last 10 years cases of transfusion-transmitted malaria have 
been reported in a number of countries: two in France19; two in Italy, 
three in Brazil10, 21 and one in USA28, one in Republic of Korea25; one in 
United Kingdom22. 
CASE REPORT
We describe a case of transfusion-transmitted malaria due to P. 
malariae from an asymptomatic donor attended in a private blood bank 
in the city of Sao Paulo. On August 12th 2008, a patient was admitted 
for cardiac surgery and received five units of red blood cells, 10 of 
cryoprecipitate, 20 of platelets and 15 of fresh frozen plasma from 
50 different donors. This patient had always lived in Sao Paulo city 
and denied any previous transfusion before this surgery or of having 
traveled to malaria endemic areas, including low-endemicity ones, such 
as Atlantic Forest. The patient had negative serological tests for malaria 
before transfusion (Table 1). On October 27th 2008 he developed fever, 
chills, arthralgia and sweating. Laboratory tests were carried out and the 
thick films from peripheral blood showed the presence of P. malariae. 
As this recipient received five units of red blood cells, the respective 
donors were recalled for epidemiological investigation and to perform 
thick films, PCR and serology. Four out of five donors attended the 
recall, all of them living in Sao Paulo. Only one donor (045-0) presented 
positive tests (Table 1, Fig. 1, Fig. 2). Since 1983 this donor traveled on 
a number of occasions to Juquia City, located in the Atlantic Forest area 
of Sao Paulo State, and where sporadic cases of autochthonous malaria 
are described. His last visit was in December 2007. Previously, he had 
last donated blood in 1990. On examination his thick film showed scarce 
parasites without clear species determination (Fig. 1A). Nested PCR 
based on the detection of species-specific sequences of small-subunit 
rRNA genes of Plasmodium32 was done, and revealed the presence of P. 
malariae in the donor’s blood (Fig. 1B). Sera archives of the recipient 
and of 48 blood donors were recovered and analyzed for the presence 
of malarial antibodies using an IgG IFAT with P. malariae antigen, an 
ELISA8 with P. vivax recombinant antigen (rPvMSP119) and an ELISA 
using total extract of P. falciparum asexual forms. The P. malariae IFAT17 
was positive only in donor 045-0 (Fig. 1C). The P. vivax ELISA was 
reactive with the sera from the infected donor (045-0) and two of the 
other 48 donors’ archive sera (Fig. 2). All archive sera were negative in 
the P. falciparum ELISA. Both the blood donor and the recipient were 
treated successfully. 
DISCUSSION
In Sao Paulo State, from 1980 to 2007, 821 autochthonous cases of 
malaria were reported; 91.6% occurred in the eastern region and these 
were predominantly due to P. vivax, as determined by microscopy; 9.6% 
of cases were asymptomatic9. It is important to note that the diagnosis of P. 
Table 1
Molecular, parasitological and serological test results from receptor before and after transfusion, and from the infected donor related to transfusional malaria
Tests Receptor Infected donor
Before transfusion After transfusion
PCR ND ND P. malariae
TBS ND P. malariae Plasmodium sp
IFAT-Pm Negative ND Positive
ELISA Pf Negative ND Negative
ELISA Pv-MSP119 Negative ND Positive
PCR - polymerase chain reaction; TBS - thick blood smear; IFAT - indirect fluorescent assay test; ELISA - Enzyme-linked immunosorbent assay; ND - not done.
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vivax by thick film was not confirmed by PCR because this methodology 
is only available in the reference center. Due to the usually low level 
parasitaemia encountered in these clinical cases it is extremely difficult 
to differentiate P. vivax from P. malariae. 
Symptomless infections with low parasitemia, confirmed by 
molecular tools as P. malariae, can occur in the Atlantic Forest area. 
Transfusion-transmitted malaria is a possibility associated with donors 
who either live in or have traveled to this area, reinforcing the need to 
monitor these donations. Three recent cases related to P. malariae, two 
of them in splenectomized receptors, including one lethal, originated 
from infectious donations from asymptomatic donors10,21. Tests carried 
out to detect the donors involved in the transmission showed high titers 
against P. malariae in IFAT and positive PCR. They had no report of 
traveling to Amazon region, although had visited the Atlantic Forest 
area in the State of Sao Paulo, where sporadic autochthonous cases have 
persistently been reported. Similar cases may have occurred without 
being identified. 
According to Brazilian legislation29 no malaria tests are mandatory 
in blood donors living in non-endemic areas, but they are deferred for 
donation for six months if they have traveled to endemic or autochthonous 
malaria transmission regions. 
This report is relevant because the transmission occurred despite 
a careful interview with the blood donors when they were asked about 
previous residence in and travel to endemic areas. This measure was 
not able to prevent transfusion transmission of malaria, since the donor 
had traveled to an area with very low transmission rates and where 
symptomless malaria cases occur, mainly due to P. malariae. The 
limited knowledge about the epidemiology of the disease in the low 
transmission regions by health professionals also contributes to failure in 
donor screening. In this case, the donor remained asymptomatic and had 
traveled to a low transmission area eight months before blood donation, 
indicating that the six months period of deferral on its own is not sufficient 
in such situations. Furthermore, increasing the deferral period to exclude 
candidates whose displacement occurred more than six months before 
the donation could affect blood supply drastically. The use of nested 
PCR in this case allowed the diagnosis of very low parasitemia in the 
blood donor, since this method can detect one parasite per microlitre32. 
This result was corroborated with the homologous antigen P. malariae in 
IFAT. This serological technique as well as ELISA is commonly used to 
detect malarial antibodies. DODERER et al.11 compared two serological 
assays and obtained clinical sensitivity of 84.2% and specificity of 99.6% 
by DiaMed ELISA and 70.5% and 99.6% respectively, using the IFAT 
method. SEED et al.31 used an enzyme-linked immunoassay (Newmarket) 
and the results pointed out to the usefulness of a screening strategy 
combining antibody testing with a 6-month cellular component restriction 
period for donors with a declared malarial risk. Recently the restriction 
period was shortened to 4-month combined with a sensitive antibody 
screening test for donors with malarial risk and the risk of transfusional 
malaria in Australia remains low30. In France, a multicentre study was 
performed in nine blood banks to compare IFAT and DiaMed ELISA, 
obtaining a rate of concordance of 92.6% in retrospective samples and 
97% in the prospective group, corroborating with the potential use of 
ELISA test in blood bank screening, as an alternative to the IFAT in 
non-endemic areas14. Since all human Plasmodia have been implicated 
in transfusional malaria, a new assay based on detection of antibodies 
anti MSP119 of P. falciparum, P. malariae, P. ovale and P. vivax is now 
available26.
Non-endemic countries have discussed measures in order to prevent 
transfusional malaria. In France, a successful strategy has been in use 
since 1986, based on self-exclusion, questionnaire, medical interview and 
serological screening prior to blood donation. Individuals who have had 
malaria in the past are permanently deferred. These measures lead to the 
reduction of five- to 10-fold in the number of cases. Three transfusional 
accidents notified from 1999 to 2006 were due to failure on data obtained 
by the questionnaires and lack of prescription of serology. According to 
French and British hemovigilance networks, no transfusional malaria in 
both countries was a consequence of missed serological positivity. Blood 
transfusion services, in a number of other non-endemic countries, are also 
Fig. 1 - 1A - Plasmodium with atypical morphology in thin blood smear from asymptomatic 
donor living in low transmission area. 1B - Nested PCR based on the detection of species-
specific sequences of small-subunit rRNA genes, showing Plasmodium malariae bands (144 
bp) of donor sample (D), positive control (K+) and 100 bp marker (M). 1C - IFAT of infected 
donor serum with P. malariae antigen.
Fig. 2 - Reactivity index of four red blood cells donors (red dots), 44 other blood components 
donors (blue dots), 1 platelet recipient from the infected donor (green dot) and the Plasmodium 
malariae infected recipient, before transfusion (purple dot), using ELISA with rPvMSP119.
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currently considering the adoption of serology. Therefore, an adequate 
strategy for minimizing the risk of malaria transmitted by blood in non-
endemic areas without losing donations is a combination of suitable donor 
selection and deferral together with screening for malarial antibodies19.
In our case, it is important to review the criteria adopted in the clinical-
epidemiological trials recommended by Brazilian guidelines, in order to 
ensure that the appropriate and effective donor selection guidelines are 
developed to implement suitable screening strategies to ensure blood safety. 
This review must consider including additional and relevant questions such 
as: place of birth, previous malaria history, residence during donor’s lifetime 
and travel history, even if they have traveled only to areas of low endemicity. 
Recent and accurate data on malaria prevalence and incidence must be 
available for Transfusion Centers to avoid failure in the identification of 
low transmission areas where symptomless cases can occur. In the Atlantic 
Forest of Sao Paulo State P. malariae was first reported based on molecular 
diagnosis after the investigation of a case of transfusion-transmitted 
malaria21. This species of Plasmodium is genetically indistinguishable of 
P. brasilianum with respect to the CSP gene15 and also to two other nuclear 
genes, SSUrRNA and the protein-encoding MSP-133. DUARTE et al.13 
tested by PCR blood samples from Alouatta guariba clamitans from the 
Sao Paulo Atlantic Forest and detected 5.6% of P. malariae and 5.6% of 
P. vivax. Since there are many summer holiday residences near the forest 
it is thought that malaria probably occurs as a zoonosis in this area.
The introduction of a serological test for malaria, together with good 
donor selection guidelines, could lead to the deferral of those donors 
most likely to have asymptomatic infections and thus reduce the risk of 
transfusion-transmitted malaria in Brazil 
RESUMO
Malária transfusional: relato de caso de doador assintomático 
infectado por Plasmodium malariae
No Brasil a malária é endêmica na Amazônia, porém casos 
autóctones com baixas parasitemias ocorrem na área costeira de Mata 
Atlântica. De acordo com a legislação brasileira, não são obrigatórios 
testes para detecção de malária em doadores de sangue de áreas não-
endêmicas; entretanto são excluídos por seis meses aqueles com relato 
de deslocamento para áreas de transmissão. Este trabalho descreve um 
caso de malária transfusional ocorrido em São Paulo, Brasil, em que um 
paciente recebeu sangue infectado, desenvolvendo a doença. Ele residia 
em São Paulo e não apresentava histórico de transfusão anterior ou 
deslocamentos para áreas endêmicas, incluindo as de baixa endemicidade, 
como a Mata Atlântica. A gota espessa revelou Plasmodium malariae. Os 
doadores eram residentes em São Paulo e um deles (045-0) apresentou 
hemoscopia e PCR positivos. Este era assintomático com PCR positiva 
para P. malariae e viagem para Juquiá, Mata Atlântica de São Paulo, 
onde são descritos casos esporádicos de malária autóctone. Amostras 
de soro do receptor e de todos os doadores foram ensaiadas por ELISA 
com antígenos de P. vivax e P. falciparum e RIFI com P. malariae. O 
doador 045-0 apresentou RIFI positiva para P. malariae. ELISA-P. vivax 
foi reagente no doador infectado (045-0) e em dois dos 44 doadores. 
Todos os soros foram negativos com antígeno de P. falciparum. Este 
caso aponta a necessidade de revisão dos critérios de triagem clínico-
epidemiológica para evitar casos transfusionais e também adequar as 
estratégias de exclusão de doadores de sangue.
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